Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations | Zendy

Jihong Li | Zendy; Yoshiyuki Fukase | Zendy; Yi Shang | Zendy; Wei Zou | Zendy; José M. MuñozFélix | Zendy; Lorena Buitrago | Zendy; Johannes van Agthoven | Zendy; Yixiao Zhang | Zendy; Ryoma Hara | Zendy; Yuta Tanaka | Zendy; Rei Okamoto | Zendy; Takeshi Yasui | Zendy; Takashi Nakahata | Zendy; Toshihiro Imaeda | Zendy; Kazuyoshi Aso | Zendy; Yuchen Zhou | Zendy; Charles W. Locuson | Zendy; Dragaes̆ić | Zendy; Mark E. Duggan | Zendy; Junichi Takagi | Zendy; Roger Vaughan | Zendy; Thomas Walz | Zendy; Kairbaan HodivalaDilke | Zendy; Steven L. Teitelbaum | Zendy; M. Amin Arnaout | Zendy; Marta Filizola | Zendy; Michael A. Foley | Zendy; Barry S. Coller | Zendy

Open Access

Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations

Author(s) -

Jihong Li,

Yoshiyuki Fukase,

Yi Shang,

Wei Zou,

José M. MuñozFélix,

Lorena Buitrago,

Johannes van Agthoven,

Yixiao Zhang,

Ryoma Hara,

Yuta Tanaka,

Rei Okamoto,

Takeshi Yasui,

Takashi Nakahata,

Toshihiro Imaeda,

Kazuyoshi Aso,

Yuchen Zhou,

Charles W. Locuson,

Dragaes̆ić,

Mark E. Duggan,

Junichi Takagi,

Roger Vaughan,

Thomas Walz,

Kairbaan HodivalaDilke,

Steven L. Teitelbaum,

M. Amin Arnaout,

Marta Filizola,

Michael A. Foley,

Barry S. Coller

Publication year - 2019

Publication title -

acs pharmacology and translational science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.271

H-Index - 10

ISSN - 2575-9108

DOI - 10.1021/acsptsci.9b00041

Subject(s) - integrin , angiogenesis , receptor , chemistry , in vivo , biophysics , microbiology and biotechnology , small molecule , priming (agriculture) , pharmacology , antagonist , cancer research , biochemistry , biology , botany , germination

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research